Octapharma USA's Kerem Tokel explains how product value and supply risk should shape freight security, and why complacency remains a persistent gap.
News|Articles|July 30, 2026
To Aggregate or not to aggregation (It's not really a question)
Author(s)Korber
Breaking cases or building mixed pallets? Learn why aggregation is essential for maintaining serialized product relationships without adding costly scans, errors and operational delays.
Related to this article
At LogiPharma USA 2026, Cold Chain Technologies' Vijay Paliwal explains how manufacturers should choose between reusable, single-use and active packaging.
As HCPs turn to AI tools for clinical answers, pharma brands must optimize for share of answer over share of voice and speed up data operations.
At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
Trending on Pharmaceutical Commerce
1
How Precision and Share of Answer Will Reshape Pharma Marketing
2
How Lanes and Duration Shape Cold Chain Packaging Selection
3
Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens
4
Smart Locks, Escorts or Parcel? Matching Security to the Shipment
5